3.9 Article

Systematic chemical screening identifies disulfiram as a repositionable drug that enhances sensitivity to cisplatin in bladder cancer: A summary of preclinical studies

Journal

EUROPEAN UROLOGY SUPPLEMENTS
Volume 18, Issue 1, Pages e600-e601

Publisher

Elsevier BV
DOI: 10.1016/s1569-9056(19)30445-2

Keywords

-

Categories

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available